Risk of breast or ovarian cancer in family members who do not carry the BRCA1 or BRCA2 family mutation: Findings from the EMBRACE study.

被引：0
|
作者：
Girardi, Fable
Barnes, Daniel R.
Barrowdale, Daniel
Frost, Debra
Easton, Douglas F.
Antoniou, Antonis C.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.1558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1558
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families
    Aouatef Riahi
    Mohamel el Ghourabi
    Asma Fourati
    Habiba Chaabouni-Bouhamed
    Breast Cancer, 2017, 24 : 238 - 244
  • [12] Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families
    Riahi, Aouatef
    el Ghourabi, Mohamel
    Fourati, Asma
    Chaabouni-Bouhamed, Habiba
    BREAST CANCER, 2017, 24 (02) : 238 - 244
  • [13] The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations
    Narod, Steven A.
    Metcalfe, Kelly
    Finch, Amy
    Chan, An-Wen
    Armel, Susan Randall
    Aeilts, Amber
    Eisen, Andrea
    Karlan, Beth
    Bordeleau, Louise
    Tung, Nadine
    Foulkes, William D.
    Neuhausen, Susan L.
    Eng, Charis
    Olopade, Olufunmilayo
    Zakalik, Dana
    Couch, Fergus
    Cullinane, Carey
    Pal, Tuya
    Sun, Ping
    Kotsopoulos, Joanne
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2024, 22 (01)
  • [14] Average risks of breast and ovarian cancer in women who carry a BRCA1 or BRCA2 mutation:: a preliminary analysis of pooled family data from unselected case series.
    Pharoah, P
    Antoniou, A
    Risch, H
    Narod, S
    Hopper, J
    Loman, N
    Olson, H
    Johansson, O
    Borg, A
    Pasini, B
    Radici, P
    Eccles, D
    Tang, N
    Olah, E
    Anton-Culver, H
    Eyfjord, J
    Evans, DG
    Evans, C
    Peto, J
    Easton, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 256 - 256
  • [15] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1382 - 1384
  • [16] Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study.
    Xia, Yue Yin
    Lubinski, Jan
    Rosen, Barry
    Moller, Pal
    Eisen, Andrea
    Ainsworth, Peter
    Senter, Leigha
    Bordeleau, Louise
    Neuhausen, Susan L.
    Singer, Christian F.
    Brooks, Jennifer
    Sun, Ping
    Narod, Steven A.
    Kotsopoulos, Joanne
    CANCER RESEARCH, 2021, 81 (13)
  • [17] An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2
    Moslehi, R
    Russo, D
    Phelan, C
    Jack, E
    Antman, K
    Narod, S
    CLINICAL GENETICS, 2000, 57 (01) : 70 - 73
  • [18] Does cascading work in breast cancer families? A critical audit of BRCA1/BRCA2 mutation carriers and their at risk family members.
    Bernhard, B
    Bond, PM
    Douglas, F
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S46 - S46
  • [19] Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history
    Claus, EB
    Schildkraut, J
    Iversen, ES
    Berry, D
    Parmigiani, G
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (23) : 1824 - 1829
  • [20] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Kornhauser, Naomi
    Terry, Mary Beth
    Vahdat, Linda T.
    Andrulis, Irene
    Buys, Saundra
    Daly, Mary
    John, Esther
    Hopper, John L.
    Cigler, Tessa
    CANCER RESEARCH, 2015, 75
12345